{"id":39621,"date":"2023-12-21T10:10:45","date_gmt":"2023-12-21T10:10:45","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=39621"},"modified":"2024-07-23T10:11:48","modified_gmt":"2024-07-23T09:11:48","slug":"aimed-pioneering-antimicrobial-peptides-biomaterials-prevent-post-operation-infections","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/aimed-pioneering-antimicrobial-peptides-biomaterials-prevent-post-operation-infections\/39621\/","title":{"rendered":"AIMed: Pioneering antimicrobial peptides and biomaterials to prevent post-operation infections"},"content":{"rendered":"
Antibiotic-resistant infections are a key issue in rising mortality and morbidity rates, especially in post-operative scenarios. The risk of infections is especially high for orthopaedic surgeries, leading to a heavy financial burden on the healthcare system. This mandates the need for large-scale funding and collaborative work in order to develop a series of medical devices with enhanced antimicrobial activity and biocompatibility.<\/p>\n
The European Union\u2019s funded Antimicrobial Integrated Methodologies (AIMed) is one such multi-disciplinary and inter-sectoral effort directed towards combating orthopaedic infections. AIMed is a Marie Sklodowska-Curie Innovative Training Network (Horizon2020 MSCA-ITN), consisting of 12 beneficiaries and seven partner organisations, for training 15 early-stage researchers (ESRs) across Europe.<\/p>\n
The AIMed network promotes interdisciplinary academic research for developing next-generation orthopaedic implants<\/a> with antimicrobial properties. One of the key areas of focus is the development of novel antimicrobial peptides allowing large-scale production and fusion with biopolymers for improved delivery to infection sites.<\/p>\n Within the network, researchers are collaborating to investigate novel techniques for subsequent immobilisation and conjugation of antimicrobial peptides on potential material surfaces.<\/p>\n AIMed is co-ordinated by Professor Artemis Stamboulis<\/a> at the University of Birmingham. Professor Stamboulis leads the Biomaterials Research Group at the School of Metallurgy and Materials<\/a>, which works on the design and synthesis of novel antimicrobial peptides that mimic the antimicrobial core of human defensins.<\/p>\n<\/p>\n
AIMed\u2019s current projects<\/h3>\n